Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 6/20 | 0.89 |
| ▸ | BLM | P54132 | 4/20 | 0.87 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.87 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.77 |
| ▸ | CHRM5 | P08912 | 5/20 | 0.72 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.72 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.72 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.72 |
| ▸ | MEN1 | O00255 | 3/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.72 |
| ▸ | TSHR | P16473 | 2/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.64 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylatropine SCHEMBL30003811 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2CHRM2BLMPABPC1CYP2C19 | |
| Methylatropine SCHEMBL20798247 | 1.00 | SMN1; SMN2 (1.00) | SMN1; SMN2CHRM2BLMPABPC1CYP2C19 | |
| Methylatropine SCHEMBL34463463 | 0.94 | CHRM2 (1.00) | SMN1; SMN2CHRM2BLMPABPC1CYP2C19 | |
| Methylatropine SCHEMBL824874 | 0.94 | CHRM2 (1.00) | SMN1; SMN2CHRM2BLMPABPC1CYP2C19 | |
| Methylatropine SCHEMBL29389879 | 0.93 | PABPC1 (1.00) | SMN1; SMN2CHRM2BLMPABPC1CYP2C19 | |
| Methylatropine SCHEMBL1321572 | 0.93 | BLM (1.00) | SMN1; SMN2CHRM2BLMPABPC1CYP2C19 | |
| Methylatropine SCHEMBL30647266 | 0.93 | BLM (1.00) | SMN1; SMN2CHRM2BLMPABPC1CYP2C19 | |
| Atropine Oxide SCHEMBL29369999 | 0.87 | CYP2C19 (1.00) | SMN1; SMN2CHRM2BLMPABPC1CYP2C19 | |
| Atropine Oxide SCHEMBL98985 | 0.87 | CYP2C19 (1.00) | SMN1; SMN2CHRM2BLMPABPC1CYP2C19 | |
| Atropine Oxide SCHEMBL162929 | 0.87 | CYP2C19 (1.00) | SMN1; SMN2CHRM2BLMPABPC1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2461 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4324941-B1 | METHOD FOR PRODUCING A TUBULAR SEMI-FINISHED PRODUCT | BENTELER STEEL/TUBE GMBH & CO KG (DE) | 2026-05-06 | — | — | EP | claimed |
| US-12560872-B2 | Vacuum sheet bond fixturing and flexible burl applications for substrate tables | ASML NETHERLANDS B.V. (NL) | 2026-02-24 | — | — | US | claimed |
| US-20240139166-A1 | OPHTHALMIC COMPOSITIONS FOR PRESBYOPIA | Sydnexis, Inc. | 2024-05-02 | — | — | US | claimed |
| EP-4288049-A1 | OPHTHALMIC COMPOSITIONS FOR PRESBYOPIA | Sydnexis, Inc. (US) | 2023-12-13 | — | — | EP | claimed |
| EP-4178948-A2 | FUNCTIONALIZED ISONITRILES AND PRODUCTS, PREPARATION AND USES THEREOF | Universidade de Santiago de Compostela (ES) | 2023-05-17 | — | — | EP | claimed |
| WO-2022169959-A1 | OPHTHALMIC COMPOSITIONS FOR PRESBYOPIA | Sydnexis, Inc. (US) | 2022-08-11 | — | — | WO | claimed |
| US-20220218630-A1 | METHODS AND FORMULATIONS FOR TREATING VISION DISORDERS | JENIVISION INC. | 2022-07-14 | — | — | US | claimed |
| EP-3979996-A1 | METHODS AND FORMULATIONS FOR TREATING VISION DISORDERS | Jenivision Inc. (US) | 2022-04-13 | — | — | EP | claimed |
| US-20220087980-A1 | METHODS OF USING DANTROLENE TO TREAT NERVE AGENT EXPOSURE | EAGLE PHARMACEUTICALS, INC. | 2022-03-24 | — | — | US | claimed |
| WO-2022023496-A2 | FUNCTIONALIZED ISONITRILES AND PRODUCTS, PREPARATION AND USES THEREOF | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2022-02-03 | — | — | WO | claimed |
| WO-1993009764-A1 | COMBINED VIRUSTATIC ANTIMEDIATOR (COVAM) TREATMENT OF COMMON COLDS | CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1993-05-27 | — | — | WO | claimed |
| EP-0527940-A1 | DIRECT SPRAY-DRIED DRUG/LIPID POWDER COMPOSITION | LIPOSOME TECHNOLOGY, INC. (US) | 1993-02-24 | — | — | EP | claimed |
| EP-0496138-A1 | Atropine-salbutamol aerosol | Euroceltique S.A. (LU) | 1992-07-29 | — | — | EP | claimed |
| WO-1991016882-A1 | DIRECT SPRAY-DRIED DRUG/LIPID POWDER COMPOSITION | LIPOSOME TECHNOLOGY, INC. (US) | 1991-11-14 | — | — | WO | claimed |
| US-5049389-A | Non-phospholipd lipid, delivery by inhalation | LIPOSOME TECHNOLOGY, INC. (US) | 1991-09-17 | — | — | US | claimed |
| WO-1990006775-A1 | A NOVEL NONPHOSPHOLIPID LIPOSOME COMPOSITION FOR SUSTAINED RELEASE OF DRUGS | LIPOSOME TECHNOLOGY, INC. (US) | 1990-06-28 | — | — | WO | claimed |
| US-4895719-A | SUSPENSION, ENCAPSULATION, DRUG DELIVERY | LIPOSOME TECHNOLOGY, INC. (US) | 1990-01-23 | — | — | US | claimed |
| EP-0223831-A4 | LIPOSOME INHALATION METHOD AND SYSTEM. | LIPOSOME TECHNOLOGY INC (US) | 1987-10-12 | — | — | EP | claimed |
| EP-0223831-A1 | LIPOSOME INHALATION METHOD AND SYSTEM. | LIPOSOME TECHNOLOGY INC (US) | 1987-06-03 | — | — | EP | claimed |
| WO-1986006959-A1 | LIPOSOME INHALATION METHOD AND SYSTEM | LIPOSOME TECHNOLOGY, INC. (US) | 1986-12-04 | — | — | WO | claimed |